These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11540095)

  • 21. Evaluation of gastrointestinal motility directly from human pharmacokinetic data.
    Roush JA
    Int J Pharm; 2011 Oct; 419(1-2):43-51. PubMed ID: 21784142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The developability classification system: application of biopharmaceutics concepts to formulation development.
    Butler JM; Dressman JB
    J Pharm Sci; 2010 Dec; 99(12):4940-54. PubMed ID: 20821390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a physiology-based model for the prediction of oral absorption in monkeys.
    Willmann S; Edginton AN; Dressman JB
    Pharm Res; 2007 Jul; 24(7):1275-82. PubMed ID: 17373575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring a Kinetic Model Approach in Biopharmaceutics: Estimating the Fraction Absorbed of Orally Administered Drugs in Humans.
    Chiang PC; Liu J; Fan P; Wong H
    J Pharm Sci; 2018 Jul; 107(7):1798-1805. PubMed ID: 29574230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring Multicompartment Plug Flow-Based Model Approach in Biopharmaceutics: Impact of Stomach Setting and the Estimation of the Fraction Absorbed of Orally Administered Basic Drugs.
    Chiang PC; Nagapudi K; Dolton MJ; Liu J
    J Pharm Sci; 2020 Mar; 109(3):1261-1269. PubMed ID: 31836377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A compartmental absorption and transit model for estimating oral drug absorption.
    Yu LX; Amidon GL
    Int J Pharm; 1999 Sep; 186(2):119-25. PubMed ID: 10486429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds.
    Zhang T; Heimbach T; Lin W; Zhang J; He H
    J Pharm Sci; 2015 Sep; 104(9):2795-806. PubMed ID: 25690565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects.
    Constantinides PP
    Pharm Res; 1995 Nov; 12(11):1561-72. PubMed ID: 8592652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions.
    Thelen K; Coboeken K; Willmann S; Burghaus R; Dressman JB; Lippert J
    J Pharm Sci; 2011 Dec; 100(12):5324-45. PubMed ID: 21993815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption sites of orally administered drugs in the small intestine.
    Murakami T
    Expert Opin Drug Discov; 2017 Dec; 12(12):1219-1232. PubMed ID: 28920464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An interesting relationship between drug absorption and melting point.
    Chu KA; Yalkowsky SH
    Int J Pharm; 2009 May; 373(1-2):24-40. PubMed ID: 19429285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the full potential of the biopharmaceutics classification system reached?
    Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
    Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling and mechanistic approaches for oral absorption: quality by design in action.
    Yu L; Zhang X; Lionberger R
    Ther Deliv; 2012 Feb; 3(2):147-50. PubMed ID: 22834193
    [No Abstract]   [Full Text] [Related]  

  • 34. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A physiological model for the estimation of the fraction dose absorbed in humans.
    Willmann S; Schmitt W; Keldenich J; Lippert J; Dressman JB
    J Med Chem; 2004 Jul; 47(16):4022-31. PubMed ID: 15267240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for absorption screening in drug discovery and development.
    Bohets H; Annaert P; Mannens G; Van Beijsterveldt L; Anciaux K; Verboven P; Meuldermans W; Lavrijsen K
    Curr Top Med Chem; 2001 Nov; 1(5):367-83. PubMed ID: 11899103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
    Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications.
    Cho HJ; Kim JE; Kim DD; Yoon IS
    Drug Dev Ind Pharm; 2014 Aug; 40(8):989-98. PubMed ID: 23981203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of drug permeability in a flat or distended stirred intestine. Prediction of fraction dose absorbed in humans after oral administration.
    Chiou WL
    Int J Clin Pharmacol Ther; 1994 Sep; 32(9):474-82. PubMed ID: 7820330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.